Avenue Therapeutics (NASDAQ:ATXI) Shares Scheduled to Reverse Split on Friday, April 26th

Avenue Therapeutics, Inc. (NASDAQ:ATXI)’s stock is scheduled to reverse split before the market opens on Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, April 26th.

Avenue Therapeutics Price Performance

Shares of ATXI stock traded down $0.04 during trading on Wednesday, reaching $0.09. The company had a trading volume of 12,284,611 shares, compared to its average volume of 4,543,282. The firm’s 50 day simple moving average is $0.15 and its two-hundred day simple moving average is $0.21. Avenue Therapeutics has a one year low of $0.09 and a one year high of $1.25. The company has a market capitalization of $4.17 million, a PE ratio of -0.07 and a beta of -0.24.

Avenue Therapeutics (NASDAQ:ATXI) last released its earnings results on Monday, March 18th. The company reported $0.56 earnings per share (EPS) for the quarter.

Avenue Therapeutics Company Profile

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.